We next tested whether JAM-A expression would influence breast cancer proliferation using an in ovo/semi-in vivo approach by performing JAM-A gene silencing in cells implanted on the chick embryo chorioallantoic membrane (CAM), as previously described [39]. The gene discussed is F11R; the disease is breast carcinoma.